RoosterBio is introducing a new product for highly efficient bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs) that we are calling RoosterReplenish-MSC. This innovative, first-in-class stem cell product is a concentrated bioreactor feed that replaces nutrients and growth factors that have been depleted during microcarrier expansion of hMSCs and replaces the need for a media exchange, enabling scalable and efficient fed-batch hMSC bioreactor expansion processes. This is the first of several new products that we will launch enabling a cell therapy and tissue engineering bioprocess revolution that will be the foundation of a sustainable Regenerative Medicine Industry. Read More
INTRODUCTION:

 

Human Mesenchymal Stem/Stromal Cells, or hMSC, are key components of future therapeutics, engineered tissues, and medical devices and are currently in use in over 400 clinical trials (1). Bone marrow-derived MSC (hBM-MSC) have historically been the most widely used hMSC, but hMSC can be isolated from many tissues of the body including fat, umbilical cord blood, dental pulp, Wharton’s...
Read More
We are always looking for ways to enable the commercialization of Cell-based Therapies and Technologies. The ultimate success of the field is dependent on the convergence of several technology fields, and one that isn't given sufficient attention is the Measurement Sciences (or metrology). The National Institute of Standards and Technology (NIST) has a Biosystems and Biomaterials Divisionthat... Read More

A"Golden Age" is defined as a period of time in a field where "great tasks are accomplished." The ancient Greek philosopher Hesiod initially coined this phrase, and I think if he were alive today, he would agree with us that we are in a special time of technology convergence where innovations and advancements are progressing at an accelerating rate. The fields of Tissue Engineering and Regenerat... Read More

Read More
Last week was the 4th Annual IBC Cell Therapy Bioprocessing Conference. IBC (home of the BioProcess International conference) was the first conference organizer to dedicate a focused meeting on Cell Therapy Manufacturing Technologies 4 years ago. Since the first conference in 2011, the growth in the field, and the conference, has been amazing. The attendance has grown from less than 90 in year 1...
Read More
From www.CellTherapyWonk.com
Fall is almost here, and that means it is Cell Therapy BioProcessing and Manufacturing conference season. This year it started a few weeks earlier as conference organizer CHI put together a Cell Therapy BioProduction session as part of their Annual BioProcessing Summit in Boston from August 18-22. In our last post (Scale-up Production – Post 1 of 2), I summarized some...
Read More
Closed system 10 layer and media bags are
now readilyavailable from several vendors.
Fall is almost here, and that means it is Cell Therapy BioProcessing and Manufacturing conference season. This year, it started a few weeks earlier as conference organizer CHI put together a Cell Therapy BioProduction session as part of their Annual BioProcessing Summitin Boston from August 18-22. It is always...
Read More